DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Treosulfan is an investigational drug.
There have been 35 clinical trials for Treosulfan. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2007.
The most common disease conditions in clinical trials are Leukemia, Preleukemia, and Myelodysplastic Syndromes. The leading clinical trial sponsors are medac GmbH, National Cancer Institute (NCI), and Fred Hutchinson Cancer Research Center.
Recent Clinical Trials for Treosulfan
|Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders||National Cancer Institute (NCI)||Phase 2|
|Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Thiotepa in Treating Patients With Non-malignant Disorders||Fred Hutchinson Cancer Research Center||Phase 2|
|Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With Posaconazole||Ciceri Fabio||Phase 2|